Linde to invest $1 billion in Arizona for semiconductor gas supply

Key facts

• Linde will invest $1 billion in Phoenix, Arizona.
• Linde's investment will expand its industrial gases complex.
• The expansion includes two new air separation units.
• Linde will supply ultra-high-purity gases to a semiconductor manufacturer.
• Eli Lilly and Resilience will invest $750 million.
• The investment will expand U.S. pharmaceutical manufacturing capacity.
• The investment aims to bolster the domestic medicine supply chain.
• 400 new jobs will be created in Ohio.
• Production of critical medicines, including Lilly's KwikPen device, will increase.

Linde plans a significant investment of approximately $1 billion to expand its industrial gases complex located in Phoenix, Arizona. This expansion is driven by a new long-term agreement to supply ultra-high-purity gases to a major semiconductor manufacturer. The project will involve the construction of two new air separation units, enhancing Linde's capacity to meet the demands of the semiconductor industry.

In parallel, Eli Lilly and contract manufacturer Resilience are committing a combined $750 million to expand pharmaceutical manufacturing capabilities within the United States. This initiative aims to strengthen the domestic medicine supply chain. The investment is projected to generate 400 new jobs in Ohio. It will also boost the production of essential medications, notably including Eli Lilly's KwikPen device, contributing to a more robust national supply of critical pharmaceuticals.